Hyaluronic Acid Glans/Girth Filler
Injectable Hyaluronic Acid for Glans and Shaft Girth Augmentation
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not FDA approved for penile augmentation (off-label use of dermal fillers)
Reference only. Not medical advice.
What can go wrong
Documented complications include palpable nodules, lumpiness, asymmetry, infection, filler migration, and resorption requiring repeat treatment; rare vascular injection can cause skin necrosis. Because penile HA use is off-label and evidence is limited, outcomes depend heavily on injector skill and product. The procedure should be performed by a qualified clinician after counseling on its temporary, unapproved nature.
This is something to take to a clinician. The Atlas can tell you what is known about hyaluronic acid glans/girth filler in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Hyaluronic acid (HA) injection is increasingly marketed for penile girth and glans augmentation as a less invasive, reversible alternative to fat transfer or silicone implants. HA is a biodegradable gel that adds temporary volume and, unlike permanent fillers such as PMMA, can be partially dissolved with hyaluronidase. No HA product is FDA approved for penile augmentation; use is off-label, evidence is limited to small series, results are temporary (often months to a couple of years), and complications include nodules, asymmetry, migration, and rare vascular injury.
A temporary, reversible girth filler marketed widely, but with no FDA approval for the penis and limited rigorous data.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
- Girth augmentation (off-label)
- Subcutaneous shaft injection to increase flaccid and erect circumference; marketed as minimally invasive and reversible.
- Glans augmentation (off-label)
- Injection into the glans for volume, sometimes promoted for premature ejaculation by reducing glans sensitivity, with weak evidence.
How it is supposed to work
HA is a naturally occurring glycosaminoglycan that binds water and provides volume. Cross-linked formulations resist enzymatic breakdown longer than native HA, prolonging the volumizing effect. Placed in the loose subcutaneous tissue of the penile shaft or glans, it increases girth or glans bulk until it is metabolized. It has no effect on erectile function or length.
HA is injected into the subcutaneous (dartos) plane of the shaft or into the glans to increase circumference. It does not enter or enlarge the erectile bodies; it adds a volumizing layer external to the tunica albuginea. The material is gradually broken down by tissue hyaluronidase, which is why the effect is temporary and why injected hyaluronidase can be used to reverse or correct it.
Safety in detail
Injectable penile filler is a medical procedure with significant physiological effects and requires a qualified clinician. It is not FDA approved for the penis; documented risks include nodules, asymmetry, migration, infection, and rare vascular injury. Self-injection or use of non-medical-grade product carries serious documented harms.
What people get wrong
Often saidHA penile filler is FDA approved
ActuallyNo hyaluronic acid product is FDA approved for penile augmentation. Approved dermal fillers are used off-label, which shifts more of the safety burden onto the injector's skill and the patient's consent.
Often saidThe girth gain is permanent
ActuallyHA is biodegradable; the volume is gradually resorbed over months to a couple of years and requires repeat injections to maintain, with cumulative cost and risk.
Often saidIt is essentially risk-free because it dissolves
ActuallyReversibility lowers but does not eliminate risk. Documented complications include nodules, asymmetry, infection, migration, and rare but serious vascular occlusion if filler enters a vessel.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Penile augmentation with injectables has a troubled history: paraffin, mineral oil, free silicone, and later PMMA were all injected for girth and produced disfiguring granulomas and complications, leading to bans in many jurisdictions. Hyaluronic acid entered this space from facial aesthetics as a reversible, biodegradable alternative, gaining traction through cosmetic and men's-health clinics in the 2010s and 2020s despite the absence of penile-specific FDA approval.
At a glance
- Material
- Cross-linked hyaluronic acid gel
- Target
- Girth (shaft circumference) and glans volume
- FDA status for penis
- Not approved (off-label cosmetic use)
- Duration
- Temporary (commonly months up to ~1-2 years)
- Reversibility
- Partially reversible with hyaluronidase
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Hyaluronic Acid Glans/Girth Filler. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Small clinical series of HA glans/penile augmentationvarious
Short-term series report measurable girth increase and patient satisfaction, but studies are small, often industry- or clinic-driven, lack long-term controlled follow-up, and document nodularity, asymmetry, and resorption.
Comparative filler-safety literature (HA versus permanent fillers)various
HA is favored over permanent injectables (PMMA, silicone, mineral oil) because it is biodegradable and reversible with hyaluronidase; permanent fillers carry far higher rates of granuloma, deformity, and need for surgical excision.